Ivermectin decreases triglyceride accumulation by inhibiting adipogenesis of 3T3-L1 preadipocytes
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 131, 110576
Abstract
No abstract availableKeywords
Funding Information
- Department of Food Science and F. J. Francis Endowment
- University of Massachusetts Amherst
This publication has 75 references indexed in Scilit:
- The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin PathwaysJournal of Biological Chemistry, 2010
- Transcriptional Regulation of Adipogenesis by KLF4Cell Metabolism, 2008
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-reviewThe AAPS Journal, 2008
- The Krüppel-like Factor KLF2 Inhibits Peroxisome Proliferator-activated Receptor-γ Expression and AdipogenesisJournal of Biological Chemistry, 2003
- Glycine triggers an intracellular calcium influx in oligodendrocyte progenitor cells which is mediated by the activation of both the ionotropic glycine receptor and Na+‐dependent transportersEuropean Journal of Neuroscience, 2000
- Activation of rat recombinant α1β2γ2S GABAA receptor by the insecticide ivermectinEuropean Journal of Pharmacology, 2000
- PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2AGenes & Development, 1997
- Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulusEuropean Journal of Clinical Pharmacology, 1996
- Environmental assessment of avermectins by the US food and drug administrationVeterinary Parasitology, 1993
- Ivermectin: A Potent New Antiparasitic AgentScience, 1983